Search
for
Sort by
Research 661–690 of 674
- Unveiling the Nuances of Adult Female Acne: A Comprehensive Exploration of Epidemiology, Treatment Modalities, Dermocosmetics, and the Menopausal Influence
- C‐reactive protein as a novel biomarker for vitamin D deficiency in alopecia areata
- The Multisystem Impact of Long COVID: A Comprehensive Review
- Non‐biologic immunosuppressive drugs for inflammatory and autoimmune skin diseases
- Sebaceous gland diseases: clinical picture risk factors and treatment
- Rare Cutaneous Side Effects of Imiquimod: A Review on Its Mechanisms, Diagnosis, and Management
- Diphenylcyclopropenone and platelet‐rich plasma in the management of severe or recalcitrant alopecia areata
- Cell Therapy for Androgenetic Alopecia: Elixir or Trick?
- Assessment of Multidimensional Health Care Parameters Among Adults in Japan for Developing a Virtual Human Generative Model: Protocol for a Cross-sectional Study
- Editor's evaluation: Involvement of ILC1-like innate lymphocytes in human autoimmunity, lessons from alopecia areata
- DataSheet1_Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention.PDF
- Acne Vulgaris
- Subject Index
- Triton modified polyethyleneimine conjugates assembled with growth arrest-specific protein 6 for androgenetic alopecia transdermal gene therapy
- Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses
- Alopecia universalis with IL-12-RB1 and STAT4 mutations effectively treated with upadacitinib
- A Case of Steatocystoma Multiplex in a Psoriatic Patient during Treatment with Anti-IL-12/23
- A systematic review of tumor necrosis factor-α blockers, anti-interleukins, and small molecule inhibitors for dissecting cellulitis of the scalp treatment
- Biologic Therapies and Small-Molecule Inhibitors for Dissecting Cellulitis of the Scalp: A Systematic Review
- 265 Modulation of disease-central cytokine pathways with TAK-279, a highly selective oral tyrosine kinase 2 (TYK2) inhibitor, defines clinical response in patients with psoriasis
- 314 Molecular genetic dissection of ILVEN leads to successful targeted therapy
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Learning From Success and Failure: Biologics for Non-approved Skin Diseases
- Dissecting Cellulitis of the Scalp: Linking Pathogenesis to Therapy
- Update on hidradenitis suppurativa: connecting the tracts
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Biologics and Small Molecules for Inflammatory Nail Disorders: A Narrative Review
- Advances in the Molecular Pathogenesis and Targeted Therapy of Psoriasis
- Effective use of ustekinumab in a patient with concomitant psoriasis, vitiligo, and alopecia areata